News & Updates

ICS in COPD: Is three better than two?

Asthmatics face high cancer risk

The risk of developing cancer appears to be elevated among people with asthma, reports a recent study.

Noninvasive home ventilation improves outcomes in COPD with chronic respiratory failure

Chronic obstructive pulmonary disease (COPD) patients with chronic respiratory failure fare well with noninvasive home ventilation treatment, which cuts the risk of death and healthcare utilization, a study has found.

Canakinumab hits mark in COVID-19-related pneumonia

The interleukin (IL)-1β antibody canakinumab has demonstrated a promising efficacy signal in patients with COVID-19-related pneumonia, reducing the need for invasive mechanical ventilation and improving clinical status, according to a study.

Flu risk in cancer survivors may hint at severe COVID-19 risk

A study from England suggests that cancer survivors, particularly haematological cancer survivors, may have a long-term risk of hospitalization or death from influenza compared with individuals with no history of cancer. The study authors believe these findings may help identify cancer survivors at risk for severe COVID-19 outcomes.

COVID-19 patients most infectious in 1st week of symptom onset

People infected with SARS-CoV-2 appear to be highly infectious within the first week following symptom onset, with the highest viral load and live virus detected during this period, according to a systematic review and meta-analysis of three human coronaviruses.

First-line lorlatinib trumps crizotinib for advanced ALK+ lung cancer

The novel third-generation ALK* inhibitor lorlatinib outdid the first-generation inhibitor crizotinib as treatment for previously untreated advanced ALK+ non-small-cell lung cancer (NSCLC), according to the interim results of the CROWN trial.

Decannulation delayed by chronic neurological conditions in preemies with BPD

Chronic neurologic conditions delay the time to tracheostomy decannulation among premature infants with severe bronchopulmonary dysplasia (BPD), a new study has found.

Poor physical performance raises red flag for CV hospitalization in COPD patients

Patients with chronic obstructive pulmonary disorder (COPD) who perform poorly on the 6-min walk test (6MWT) are at increased risk of cardiovascular (CV)-related hospitalizations, a study has found.

ICS use in COPD, asthma does not affect COVID-19-related mortality

Regular use of inhaled corticosteroids (ICS) for the treatment of chronic obstructive pulmonary disease (COPD) or asthma does not appear to affect COVID-19-related mortality, an observational study from England showed.